Forthright Family Wealth Advisory’s Boston Scientific BSX Stock Holding History

Forthright Family Wealth Advisory’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,022	Closed	-$275K	–	61
2026 Q1	$275K	Buy	4,022 +1,105	+38%	+$88.4K	0.18%	50
2025 Q4	$278K	Sell	2,917 -242	-8%	-$23.7K	0.17%	41
2025 Q3	$308K	Buy	3,159 +11	+0.3%	+$1.14K	0.19%	49
2025 Q2	$338K	Buy	3,148 +7	+0.2%	+$708	0.21%	43
2025 Q1	$317K	Hold	3,141	–	–	0.21%	43
2024 Q4	$281K	Sell	3,141 -134	-4%	-$11.8K	0.18%	46
2024 Q3	$295K	Sell	3,275 -1,043	-24%	-$82.2K	0.19%	47
2024 Q2	$333K	Buy	4,318 +296	+7%	+$21.7K	0.21%	51
2024 Q1	$275K	Hold	4,022	–	–	0.18%	50
2023 Q4	$233K	Buy	+4,022	New	+$215K	0.18%	45

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Milford Funds Auckland $6.14B AUM

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

Forthright Family Wealth Advisory's BSX Position: Q2 2026 in Review

Forthright Family Wealth Advisory sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,022 shares — an estimated $275K sold.

Forthright Family Wealth Advisory first reported a position in BSX in Q4 2023 and held it in 10 quarters. The position peaked at $338K in Q2 2025. 534 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Forthright Family Wealth Advisory reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Forthright Family Wealth Advisory sold 4,022 Boston Scientific shares in Q2 2026, an estimated $275K.
Forthright Family Wealth Advisory first reported a position in Boston Scientific in Q4 2023 and held it in 10 quarters.
Forthright Family Wealth Advisory's Boston Scientific position peaked at $338K in Q2 2025.
534 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Forthright Family Wealth Advisory's 13F filing for Q2 2026, filed 16 Jul 2026.